Raymond James & Associates Lemaitre Vascular Inc Transaction History
Raymond James & Associates
- $150 Billion
- Q2 2024
A detailed history of Raymond James & Associates transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Raymond James & Associates holds 28,844 shares of LMAT stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,844
Previous 29,481
2.16%
Holding current value
$2.59 Million
Previous $1.96 Million
21.32%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding LMAT
# of Institutions
266Shares Held
20.3MCall Options Held
3.6KPut Options Held
900-
Black Rock Inc. New York, NY3.48MShares$312 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$174 Million2.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$140 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.15MShares$103 Million1.81% of portfolio
-
Geneva Capital Management LLC880KShares$78.9 Million1.33% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $1.97B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...